Oxidized lipids enhance RANKL production by T lymphocytes : implications for lipid-induced bone loss

Osteoporosis is a systemic disease that is associated with increased morbidity, mortality and health care costs. Whereas osteoclasts and osteoblasts are the main regulators of bone homeostasis, recent studies underscore a key role for the immune system, particularly via activation-induced T lymphocy...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 133(2009), 2 vom: 15. Nov., Seite 265-75
1. Verfasser: Graham, Lucia S (VerfasserIn)
Weitere Verfasser: Parhami, Farhad, Tintut, Yin, Kitchen, Christina M R, Demer, Linda L, Effros, Rita B
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2009
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, N.I.H., Extramural Dietary Fats Isoprostanes Lipids Lipoproteins, LDL NF-kappa B OLR1 protein, human Osteoprotegerin Phosphatidylcholines mehr... RANK Ligand Scavenger Receptors, Class E TNFSF11 protein, human Transcription Factor RelA oxidized low density lipoprotein oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine Dinoprostone K7Q1JQR04M 8-isoprostaglandin E2 W1ANC8Q5NW
LEADER 01000naa a22002652 4500
001 NLM190850620
003 DE-627
005 20231223190057.0
007 cr uuu---uuuuu
008 231223s2009 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2009.07.011  |2 doi 
028 5 2 |a pubmed24n0636.xml 
035 |a (DE-627)NLM190850620 
035 |a (NLM)19699688 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Graham, Lucia S  |e verfasserin  |4 aut 
245 1 0 |a Oxidized lipids enhance RANKL production by T lymphocytes  |b implications for lipid-induced bone loss 
264 1 |c 2009 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 08.12.2009 
500 |a Date Revised 20.10.2021 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Osteoporosis is a systemic disease that is associated with increased morbidity, mortality and health care costs. Whereas osteoclasts and osteoblasts are the main regulators of bone homeostasis, recent studies underscore a key role for the immune system, particularly via activation-induced T lymphocyte production of receptor activator of NFkappaB ligand (RANKL). Well-documented as a mediator of T lymphocyte/dendritic cell interactions, RANKL also stimulates the maturation and activation of bone-resorbing osteoclasts. Given that lipid oxidation products mediate inflammatory and metabolic disorders such as osteoporosis and atherosclerosis, and since oxidized lipids affect several T lymphocyte functions, we hypothesized that RANKL production might also be subject to modulation by oxidized lipids. Here, we show that short term exposure of both unstimulated and activated human T lymphocytes to minimally oxidized low density lipoprotein (LDL), but not native LDL, significantly enhances RANKL production and promotes expression of the lectin-like oxidized LDL receptor-1 (LOX-1). The effect, which is also observed with 8-iso-Prostaglandin E2, an inflammatory isoprostane produced by lipid peroxidation, is mediated via the NFkappaB pathway, and involves increased RANKL mRNA expression. The link between oxidized lipids and T lymphocytes is further reinforced by analysis of hyperlipidemic mice, in which bone loss is associated with increased RANKL mRNA in T lymphocytes and elevated RANKL serum levels. Our results suggest a novel pathway by which T lymphocytes contribute to bone changes, namely, via oxidized lipid enhancement of RANKL production. These findings may help elucidate clinical associations between cardiovascular disease and decreased bone mass, and may also lead to new immune-based approaches to osteoporosis 
650 4 |a Journal Article 
650 4 |a Research Support, N.I.H., Extramural 
650 7 |a Dietary Fats  |2 NLM 
650 7 |a Isoprostanes  |2 NLM 
650 7 |a Lipids  |2 NLM 
650 7 |a Lipoproteins, LDL  |2 NLM 
650 7 |a NF-kappa B  |2 NLM 
650 7 |a OLR1 protein, human  |2 NLM 
650 7 |a Osteoprotegerin  |2 NLM 
650 7 |a Phosphatidylcholines  |2 NLM 
650 7 |a RANK Ligand  |2 NLM 
650 7 |a Scavenger Receptors, Class E  |2 NLM 
650 7 |a TNFSF11 protein, human  |2 NLM 
650 7 |a Transcription Factor RelA  |2 NLM 
650 7 |a oxidized low density lipoprotein  |2 NLM 
650 7 |a oxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine  |2 NLM 
650 7 |a Dinoprostone  |2 NLM 
650 7 |a K7Q1JQR04M  |2 NLM 
650 7 |a 8-isoprostaglandin E2  |2 NLM 
650 7 |a W1ANC8Q5NW  |2 NLM 
700 1 |a Parhami, Farhad  |e verfasserin  |4 aut 
700 1 |a Tintut, Yin  |e verfasserin  |4 aut 
700 1 |a Kitchen, Christina M R  |e verfasserin  |4 aut 
700 1 |a Demer, Linda L  |e verfasserin  |4 aut 
700 1 |a Effros, Rita B  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 133(2009), 2 vom: 15. Nov., Seite 265-75  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:133  |g year:2009  |g number:2  |g day:15  |g month:11  |g pages:265-75 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2009.07.011  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 133  |j 2009  |e 2  |b 15  |c 11  |h 265-75